Tiara™ Transcatheter Mitral Valve Replacement Study

NACompletedINTERVENTIONAL
Enrollment

157

Participants

Timeline

Start Date

March 8, 2017

Primary Completion Date

December 19, 2019

Study Completion Date

August 6, 2024

Conditions
Mitral Valve Regurgitation
Interventions
DEVICE

TIARA valve and transapical delivery system

Transcatheter mitral valve replacement

Trial Locations (20)

13353

Deutches Herzzentrum Berlin, Berlin

16321

Immanuel Klinikum Bernau und Herzzentrum Brandenburg, Bernau

20097

IRCCS Policlinico San Donato, San Donato Milanese

20132

Ospedale San Raffaele, Milan

20246

Universitasklinikum Hamburg-Eppendorf, Hamburg

28040

Hospital Clinico San Carlos, Madrid

32545

Herz- und Diabeteszentrum NRW, Bad Oeynhausen

44229

St.-Johannes-Hospital, Klinik für Innere Medizin I, Dortmund

49214

Schüchtermann-Klinik, Bad Rothenfelde

54100

Fondazione Toscana 'Gabriele Monasterio', Massa

61231

Kerckhoff Klinik Herzzentrum-Herzchirurgie, Bad Nauheim

70174

Sana Herzchirurgie Stuttgart GmbH, Stuttgart

06120

Universitätsklinikum Halle, Halle

04289

Herzzentrum Leipzig, Leipzig

Unknown

Herz-Kreislauf-Zentrum Klinikum Hersfeld Rotenburg, Rotenburg an der Fulda

Tel Aviv Medical Center, Tel Aviv

St. Antonius Hospital, Nieuwegein

00168

Fondazione Policlinico Universitario A. Gemelli - Università Cattolica del Sacro Cuore., Roma

EH16 4SA

Edinburgh Heart Centre Royal Infirmary, Edinburgh

SE59RS

King's College Hospital, London

All Listed Sponsors
lead

Shockwave Medical, Inc.

INDUSTRY

NCT03039855 - Tiara™ Transcatheter Mitral Valve Replacement Study | Biotech Hunter | Biotech Hunter